middle.news
How Anatara Lifesciences’ Anti-Obesity Compound AOC Is Shaping Its Future
1:24pm on Wednesday 25th of February, 2026 AEDT
•
Healthcare
Read Story
How Anatara Lifesciences’ Anti-Obesity Compound AOC Is Shaping Its Future
1:24pm on Wednesday 25th of February, 2026 AEDT
Key Points
Net loss narrowed to $515,000 from $1.16 million a year earlier
Anti-Obesity Project’s compound AOC shows significant weight control effects in pre-clinical studies
GaRP Phase II trial demonstrates symptom improvements in IBS patients
Completed $1.2 million capital raising, boosting cash reserves to $1.08 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ANATARA LIFESCIENCES (ASX:ANR)
OPEN ARTICLE